Total sialic acid (TSA) and lipid-associated sialic acid (LASA) concentrations were found to be significantly elevated in the sera of patients with chronic glomerulonephritis (CGN) and those with chronic renal failure (CRF) who were maintained on haemodialysis. The reference values for TSA and LASA were determined in the sera of 60 healthy subjects (33 males and 27 females) and showed no significant dependence on age and sex. No correlation existed between the TSA and LASA values, nor between TSA and LASA and the serum BUN and creatinine values in the patients and controls. A large amount of bound sialic acids was excreted in the urine of both groups of patients, although the serum sialic acid levels were increased.
ErbilKMSenSEZinckeHJonesJD. Significance of serum protein and lipid-bound sialic acid as a marker for genitourinary malignancies. Cancer1986; 57: 1389–94.
2.
SpiroRG. Glycoproteins: Structure, metabolism and biology. N Engl J Med1963; 269: 566–73.
3.
HakomoriS. Structures and organization of cell surface glycolipids dependency on cell growth and malignant transformation. Biochim Biophys Acta1975; 417: 55–89.
4.
KishoreBKArakawaMGejyoF. Altered glycosylation and sialylation of serum proteins and lipid-bound sialic acids in chronic renal failure. Postgrad Med J1983; 59: 551–5.
5.
PlucinskyMCRileyWMProrokJJAlhadeffJA. Total and lipid-associated serum sialic acid levels in cancer patients with different primary sites and differing degrees of metastatic involvement. Cancer1986; 59: 2680–5.
6.
StefenelliNKlotzHEngelABauerP. Serum sialic acid in malignant tumors, bacterial infections, and chronic liver diseases. J Cancer Res Clin Oncol1985; 109; 55–9.
7.
SchambergerRJ. Serum sialic acid in normals and in cancer patients. J Clin Chem Clin Biochem1984; 22: 647–51.
8.
SilverHKBKarimAKArchibaldELSalinasFA. Serum sialic acid and sialyltransferase as monitors of tumor burden in malignant melanoma patients. Cancer Res1979; 39: 5036–42.
9.
WarrenL. The thiobarbituric acid assay of sialic acids. J Biol Chem1959; 234: 1971–5.
10.
LorentzKWeißTKraasE. Sialic acid in human serum and cerebrospinal fluid. J Clin Chem Clin Biochem1986; 24: 189–98.
11.
AsamiTTanakaAGunjiTSakaiK. Elevated serum and urine sialic acid levels in renal diseases of childhood. Clin Nephrol1985; 23: 112–19.
12.
GörögP. Sialic acid moieties on surface glycoproteins protect endothelial cells from proteolytic damage. J Pathol1985; 146: 205–12.
13.
LaitinenLMiettinenATikkanenITörnrothTNordlingS. Glomerular sialic acid in Heymann nephritis and diacetyl-benzidine induced nephropathy in rats. Clin Sci1985; 69: 57–62.
14.
KerjaschkiDVernilloATFarquharMG. Reduced sialylation of podocalyxin the major sialoprotein of the rat kidney glomerulus in aminonucleoside nephrosis. Am J Pathol1985; 118: 343–9.
15.
MynderseLAHassellJRKleinmanHKMartinGRMartinez-HernandezA. Loss of heparan sulphate proteoglycan from glomerular basement membrane of nephrotic rats. Lab Invest1983; 48: 292–302.
16.
QuatackerJ. Alterations in the sialic acid content of the rat glomerular filter in aminonucleoside nephrosis. Wirchows Arch (Cell Pathol)1986; 50: 237–47.
17.
AlcornDRyanBG. Distribution of anionic groups in the glomerular capillary wall in rat nephrotoxic nephritis and aminonucleoside nephrosis. Pathol1981; 13: 37–50.
18.
BlauFBHaasJE. Glomerular sialic acid and proteinuria in human renal disease. Lab Invest1973; 28: 477–81.
19.
BaggioBBrianiGCicerelloE. Urinary glycosaminoglycans, sialic acid and lysosomal enzymes increase in nonalbuminuric diabetic patients. Nephron1986; 43: 187–90.
